fda compounding semaglutide enforcement october 2025 Compounded GLP-1 Statistics 2026 | Crackdown & What Changed FDA Warns on Certain Forms

Or are they the cure that people with obesity roughly 40% of American adults have been waiting for

GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes

Mazdutide: dual agonist metabolic research material

Breast cancer survivors represent a significant portion of PlexusDx patients, and our clinical team understands the intersection of oncology, metabolic health, and weight management

Manage gallstone risk

Introduction: A Fork in the Big Pharma Road When Novo Nordisk publicly rebuked Hims & Hers for offering compounded GLP-1 medications , it wasnt just a dispute over one drugit was a proxy war for the future of medicine